The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample

Psychopharmacology

Volumn 229, Issue 1, 2013, Pages 199-208

  Acheson, Dean ^a   Feifel, David ^a   De Wilde, Sofieke ^b   McKinney, Rebecca ^a   Lohr, James ^a,c   Risbrough, Victoria ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Fear extinction; Oxytocin; Prolonged exposure; PTSD

Indexed keywords

OXYTOCIN; PLACEBO;

ADULT; ANXIETY; ARTICLE; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXPECTANCY; FATIGUE; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY CONSOLIDATION; NORMAL HUMAN; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RANDOMIZED CONTROLLED TRIAL; RECALL; REINFORCEMENT; SELF REPORT; SOCIAL PSYCHOLOGY; STARTLE REFLEX; TASK PERFORMANCE;

ADULT; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MALE; MENTAL RECALL; OXYTOCIN; STARTLE REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84881615635     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3099-4     Document Type: Article

References (48)

1. Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB (2012) The effect of pregabalin on sensory motor gating in 'low' gating humans and mice. Neuropharmacology 63:480-485
2. Acheson DT, Gresack J, Risbrough VB (2011) Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder. Neuropharmacology 62:674-685
3. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, Girolamo G, Graaf R, Demyttenaere K et al (2004) Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 109:21-27
4. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (fourth edition, text revision). Washington, DC
5. Bartels A (2012) Oxytocin and the social brain: beware the complexity. Neuropsychopharmacology 37:1795-1796
6. Baumgartner T, Heinrichs M, Vonlathen A, Fischbacher U, Fehr E (2008) Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 58:639-650
7. Bradley R, Greene J, Russ E, Dutra L, Westen D (2005) A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 162:214-227
8. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis CG, Andreski P (1998) Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 55:626-632
9. Cloitre M (2009) Effective psychotherapies for posttraumatic stress disorder: a review and critique. CNS Spectrum 14:32-43
10. Committee on Treatment of Posttraumatic Stress Disorder IoMotNA (2007) Treatment of posttraumatic stress disorder: an assessment of the evidence. The National Academies Press, Washington, DC
11. de Kleine RA, Hendriks G, Kusters WJC, Broekman TG, van Minnen A (2012) A randomized placebo-controlled trial of d-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry
12. de Oliveira DC, Chagas MH, Garcia LV, Crippa JA, Zuardi AW (2012) Oxytocin interference in the effects induced by inhalation of 7.5 % CO(2) in healthy volunteers. Hum Psychopharmacol 27(4):378-385
13. Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC (2007) Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62:1187-1190
14. Druss BG, Hwang I, Petukhova M, Sampson NA, Wang PS, Kessler RC (2008) Impairment in role functioning in mental and chronic medical disorders in the United States: results from the National Comorbidity Survey Replication. Mol Psychiatry 14:728-737
15. Etkin A, Wager TD (2007) Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 164:1476-1488
16. Feifel D (2012) Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions. Neuropsychopharmacology 37:304-305
17. Foa EB, Rothbaum BO (1998) Treating the trauma of rape: cognitive-behavioral therapy for PTSD. Guilford, New York
18. Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS (2009) A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology 34:917-923
19. Grillon C, Krimsky M, Charney DR, Vytal K, Ernst M, Cornwell B (2012) Oxytocin increases anxiety to unpredictable threat. Mol Psychiatry. doi: 10.1038/mp.2012.156
20. Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U (2003) Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54:1389-1398
21. Heinrichs M, Meinlschmidt G, Wippich W, Ehlert U, Hellhammer DH (2004) Selective amnesic effects of oxytocin on human memory. Physiol Behav 83(1):31-38
22. Hembree EA, Foa EB, Dorfan NM, Street GP, Kowalski J, Tu X (2003) Do patients drop out prematurely from exposure therapy for PTSD? J Trauma Stress 16:555-562
23. Herzmann G, Young B, Bird CW, Curran T (2012) Oxytocin can impair memory for social and non-social visual objects: a within-subject investigation of oxytocin's effects on human memory. Brain Res 1451:65-73
24. Hodgson R, Rachman S (1974) II. Desynchrony in measures of fear. Behav Res Ther 12:319-326
25. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617-627
26. Kirsch P, Esslinger C, Chen Q et al (2005) Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci 25:11489-11493
27. LaBar KS, Gatenby JC, Gore JC, LeDoux JE, Phelps EA (1998) Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20:937-945
28. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ (2010) Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology 35(12):2403-2413
29. Lukas M, Toth I, Reber SO, Slattery DA, Veenema AH, Neumann ID (2011) The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice. Neuropsychopharmacology 36(11):2159-2168
30. Milad MR, Quirk GJ (2012) Fear extinction as a model for translational neuroscience: ten years of progress. Annu Rev Psychol 63:129-151
31. Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK (2008) Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res 42:515-520
32. Milad MR, Wright CL, Orr SP, Pitman RK, Quirk GJ, Rauch SL (2007) Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry 62:446-454
33. Mueller D, Porter JT, Quirk GJ (2008) Noradrenergic signaling in infralimbic cortex increases cell excitability and strengthens memory for fear extinction. J Neurosci 28:369-375
34. Meyer-Lindengergy A, Domes G, Kirsch P, Heinrichs M (2011) Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 12:524-538
35. Myers KM, Davis M (2007) Mechanisms of fear extinction. Molecular Psychiatry 12:120-150
36. Ninan I (2011) Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J Neurochem 119(2):324-331
37. Norberg MM, Krystal JH, Tolin D (2008) A meta-analysis of D-cycloserine and facilitation of fear extinction and exposure therapy. Biol Psychiatry 63:1118-1126
38. Norrholm SD, Jovanovic T, Olin IW, Sands LA, Karapanou I, Bradley B, Ressler KJ (2011) Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biol Psychiatry 15:556-563
39. Norrholm SD, Jovanovic T, Vervliet B, Myers KM, Davis M, Rothbaum BO, Duncan EJ (2006) Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem 13:681-685
40. Olff M, Langeland W, Witteveen A, Denys D (2010) A psychobiological rationale for oxytocin in the treatment of posttraumatic stress disorder. CNS Spectrum 15:522-530
41. Petrovic P, Kalisch R, Singer T, Dolan RJ (2008) Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci 28:6607-6615
42. Phelps EA, Delgado MR, Nearing KI, LeDoux JE (2004) Extinction learning in humans: role of the amygdala and vmPFC. Neuron 43(6):897-905
43. Rescorla RA, Wagner AR (1972) A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Black AH, Prokasy WF (eds) Classical Conditioning II. Appleton-Century-Crofts, p 64-99
44. Schnurr PP, Friendman MJ, Engel CC, Foa EB, Shea M, Chow BK et al (2007) Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. JAMA 297:820-830
45. Shin LM, Rauch SL, Pitman RK (2006) Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 1071:67-79
46. Sripada CS, Phan KL, Labuschagne 2012 I, Welsh R, Nathan PJ, Wood AG (2012) Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex. Int J Neuropsychopharmacol 30:1-6
47. Striepens N, Kendrick KM, Maier W, Hurlemann R (2011) Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol 32(4):426-450
48. Toth I, Neumann ID, Slattery DA (2012) Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology